These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 17980247)

  • 1. Platelet function monitoring in patients with coronary artery disease.
    Gurbel PA; Becker RC; Mann KG; Steinhubl SR; Michelson AD
    J Am Coll Cardiol; 2007 Nov; 50(19):1822-34. PubMed ID: 17980247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current antiplatelet therapies: benefits and limitations.
    Angiolillo DJ; Guzman LA; Bass TA
    Am Heart J; 2008 Aug; 156(2 Suppl):S3-9. PubMed ID: 18657680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variability in platelet response to the antiplatelet agents aspirin and clopidogrel: mechanisms, measurement, and clinical relevance.
    Jennings LK
    Crit Pathw Cardiol; 2009 Mar; 8(1):20-8. PubMed ID: 19258834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiplatelet drug nonresponsiveness.
    Gladding P; Webster M; Ormiston J; Olsen S; White H
    Am Heart J; 2008 Apr; 155(4):591-9. PubMed ID: 18371464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use.
    Reaume KT; Regal RE; Dorsch MP
    Ann Pharmacother; 2008 Apr; 42(4):550-7. PubMed ID: 18319394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measuring antiplatelet drug effects in the laboratory.
    Harrison P; Frelinger AL; Furman MI; Michelson AD
    Thromb Res; 2007; 120(3):323-36. PubMed ID: 17239428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment, mechanisms, and clinical implication of variability in platelet response to aspirin and clopidogrel therapy.
    Ben-Dor I; Kleiman NS; Lev E
    Am J Cardiol; 2009 Jul; 104(2):227-33. PubMed ID: 19576352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of platelet function testing to guide therapy in clopidogrel low and enhanced responders.
    Bernlochner I; Byrne RA; Kastrati A; Sibbing D
    Expert Rev Cardiovasc Ther; 2011 Aug; 9(8):999-1014. PubMed ID: 21878045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clopidogrel response variability, resistance, or both?
    Wiviott SD
    Am J Cardiol; 2006 Nov; 98(10A):18N-24N. PubMed ID: 17097413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The present state of aspirin and clopidogrel resistance.
    Guyer KE
    Hamostaseologie; 2009 Aug; 29(3):285-90. PubMed ID: 19644597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet function testing and implications for clinical practice.
    Collet JP; Montalescot G
    J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):157-69. PubMed ID: 19721130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship of platelet reactivity to the occurrence of post-stenting ischemic events: emergence of a new cardiovascular risk factor.
    Gurbel PA
    Rev Cardiovasc Med; 2006; 7 Suppl 4():S20-8. PubMed ID: 17224887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute coronary syndrome: are intervention and IIb/IIIa platelet inhibitors epiphenomena?
    Jackson G
    Int J Clin Pract; 2001; 55(6):351-2. PubMed ID: 11501219
    [No Abstract]   [Full Text] [Related]  

  • 14. Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.
    Motovska Z; Kala P
    Clin Ther; 2008; 30 Pt 2():2191-202. PubMed ID: 19281914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of collagen versus adenosine diphosphate in detecting antiplatelet effect in patients with coronary artery disease.
    Li J; Jian Z; Huang L; Guo H; Huang J; Qian D; Fu W; Li A; Song Y
    Biomed Pharmacother; 2009 Sep; 63(8):608-12. PubMed ID: 19019624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of antiplatelet therapy across the spectrum of patients with coronary artery disease.
    Bhatt DL
    Am J Cardiol; 2009 Feb; 103(3 Suppl):11A-19A. PubMed ID: 19166708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unresolved issues associated with early initiation of antiplatelet therapy in acute coronary syndromes.
    Alagona P
    J Invasive Cardiol; 2010 Jan; 22(1):40-4. PubMed ID: 20048399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiplatelet agents used for early intervention in acute coronary syndrome: myocardial salvage versus bleeding complications.
    Aranki SF; Body SC
    J Thorac Cardiovasc Surg; 2009 Oct; 138(4):807-10. PubMed ID: 19769880
    [No Abstract]   [Full Text] [Related]  

  • 19. Platelet function monitoring in patients on clopidogrel: What should we learn from GRAVITAS?
    Aradi D; Komócsi A
    Platelets; 2012; 23(3):167-76. PubMed ID: 21958190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet monitoring for PCI: is it really necessary?
    Tantry US; Gurbel PA
    Hamostaseologie; 2009 Nov; 29(4):368-75. PubMed ID: 19882080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.